For diabetes patients, A1c reductions of approximately 1.0-1.5 percentage points are common with GLP-1 receptor agonists, while tirzepatide has shown reductions of up to 2.0-2.3 percentage points in clinical trials
Several ingredients genuinely support gut health and metabolic function
By comparison, semaglutide at its highest dose (2.4 mg weekly) achieved approximately 14.9% average weight loss in the STEP trials over similar timeframes
On its own, semaglutide usually doesnt result in hypoglycemia, but when combined with other blood sugar-lowering drugs like insulin, it may raise the risk
Research is still evolving, but some studies suggest intermittent fasting and time-restricted eating may positively influence hormones involved in metabolism, including GLP-1
For example, some plans might list it as a Tier 2 drug, which means its a preferred brand-name medication